Matricelf Stock Price, News & Analysis
Company Description
Matricelf (OTC Link: MTRLF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $30.7M.
MTRLF stock has gained 0.0% over the past year.
This page provides a comprehensive overview of MTRLF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
Matricelf has 7 recent news articles. Key topics include partnership. View all MTRLF news →
SEC Filings
Financial Highlights
Upcoming Events
First clinical implantation target
First-in-human trials
Matricelf has 2 upcoming scheduled events. The next event, "First clinical implantation target", is scheduled for January 1, 2027 (in 257 days). Investors can track these dates to stay informed about potential catalysts that may affect the MTRLF stock price.
Short Interest History
Short interest in Matricelf (MTRLF) currently stands at 5.0 thousand shares, up 1000.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 6310.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Matricelf (MTRLF) currently stands at 1.0 days, down 53.1% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.1 days.
MTRLF Company Profile & Sector Positioning
Matricelf (MTRLF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MTRLF often look at related companies in the same sector, including Kadimastem (KMSTF), GEMINA LABORATORIES LTD (GLABF), Thiogenesis (TTIPF), Harvard Apparatus Regenerative Technology Inc. (HRGN), and Provectus Biopha (PVCT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MTRLF's relative position within its industry.